And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda will largely encompass spending time with our tallest short person and stopping by what we think of as our natural habitat. And what about you? This is a fine time of year to start picking apples or taking long drives in the country. You could stock up on sweaters and winterize your castle. Or you could buy a sharpie and practice rewriting history. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon…

Some of the settlements in opioids lawsuits that were filed against drug makers appear to have been negotiated to take advantage of an exception, ambiguities, and weaknesses in federal tax law that allows the companies to take tax deductions, USA Today reports. In three agreements reached earlier this year, the companies did not acknowledge any wrongdoing and payments were made to foundations. Tax law experts say the settlements appear to be structured in ways that could enable write-offs at least part of the payments on their taxes.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

Your daily dose of news in health and medicine

Privacy Policy